| Total sample (n = 46,450; 100.0%) |
No new onset of diabetic kidney disease (n = 44,294; 95.4%) |
New onset of diabetic kidney disease (n = 2,156; 4.6%) |
|
|---|---|---|---|
| n (%)/mean ± SD | n (%)/mean ± SD | n (%)/mean ± SD | |
| Sex | |||
| Men | 25,922 (55.8) | 24,610 (55.6) | 1,312(60.9) |
| Women | 20,528 (44.2) | 19,684 (44.4) | 844 (39.1) |
| Age | |||
| ≤49 years | 1,705 (3.7) | 1,632 (3.7) | 73 (3.4) |
| 50-59 years | 2,561 (5.5) | 2,443 (5.5) | 118 (5.5) |
| 60-69 years | 11,824 (25.8) | 11,252 (25.4) | 572 (26.5) |
| 70-79 years | 19,084 (41.1) | 18,195 (41.1) | 889 (41.2) |
| ≥80 years | 11,276 (24.3) | 10,772 (24.3) | 504 (23.4) |
| Hypertension | |||
| Yes | 35,056 (75.5) | 33,376 (75.4) | 1,680 (77.9) |
| No | 11,394 (24.5) | 10,918 (24.6) | 476 (22.1) |
| Dyslipidemia | |||
| Yes | 32,545 (70.1) | 31,006 (70.0) | 1,539 (71.4) |
| No | 13,905 (29.9) | 13,288 (30.0) | 617 (28.6) |
| Hyperuricemia | |||
| Yes | 6,773 (14.6) | 6,375 (14.4) | 398 (18.5) |
| No | 39,677 (85.4) | 37,919 (85.6) | 1,758 (81.5) |
| Proportion of outpatient prescription days (%) | 76.2 ± 23.9 | 76.1 ± 24.0 | 79.6 ± 20.7 |
| T1 (low prescription: ≤73.96%) | 15,431 (33.2) | 14,820 (33.5) | 611 (28.3) |
| T2 (moderate prescription: 73.97-92.05%) | 13,950 (30.0) | 13,219 (29.8) | 731 (33.9) |
| T3 (high prescription: ≥92.06%) | 17,069 (36.7) | 16,255 (36.7) | 814 (37.8) |
| Total sample | Excluding those with a proportion of outpatient prescription days of <50% |
||||
|---|---|---|---|---|---|
| aHR | (95% CI) | aHR | (95% CI) | ||
| Sexa | Men | 1.22 | (1.12-1.34) | 1.19 | (1.08-1.31) |
| Ageb | 50-59 years | 1.05 | (0.79-1.41) | 1.02 | (0.73-1.42) |
| 60-69 years | 1.10 | (0.86-1.40) | 1.07 | (0.81-1.42) | |
| 70-79 years | 1.08 | (0.85-1.37) | 1.09 | (0.83-1.43) | |
| ≥80 years | 1.14 | (0.89-1.47) | 1.13 | (0.85-1.50) | |
| Hypertensionc | Yes | 1.13 | (1.02-1.25) | 1.12 | (1.00-1.25) |
| Dyslipidemiad | Yes | 1.02 | (0.92-1.12) | 1.01 | (0.92-1.12) |
| Hyperuricemiae | Yes | 1.27 | (1.13-1.42) | 1.27 | (1.13-1.43) |
| Proportion of outpatient prescription daysf | T1 (low prescription: ≤73.96%) | 0.84 | (0.75-0.93) | 1.05 | (0.93-1.19) |
| T2 (moderate prescription: 73.97-92.05%) | 1.01 | (0.92-1.12) | 1.01 | (0.92-1.12) | |
